Ted Buchan & Co Lowers Stake in SPDR S&P Biotech ETF $XBI

Ted Buchan & Co cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 97.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,169 shares of the exchange traded fund’s stock after selling 90,585 shares during the period. Ted Buchan & Co’s holdings in SPDR S&P Biotech ETF were worth $217,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in XBI. Compass Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at about $1,167,000. China Universal Asset Management Co. Ltd. grew its position in SPDR S&P Biotech ETF by 868.3% during the third quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock valued at $493,000 after acquiring an additional 4,411 shares during the last quarter. Ashton Thomas Private Wealth LLC bought a new position in SPDR S&P Biotech ETF during the third quarter valued at approximately $417,000. Altfest L J & Co. Inc. raised its stake in shares of SPDR S&P Biotech ETF by 63.1% during the third quarter. Altfest L J & Co. Inc. now owns 124,921 shares of the exchange traded fund’s stock worth $12,517,000 after acquiring an additional 48,326 shares in the last quarter. Finally, Brian Low Financial Group LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth approximately $668,000.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $127.37 on Friday. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $132.09. The company has a fifty day moving average of $125.25 and a 200-day moving average of $112.72. The stock has a market capitalization of $8.51 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.